跳至主要内容
临床试验/JPRN-UMIN000001401
JPRN-UMIN000001401已完成2 期

Phase II study of S-1 and CDDP as neoadjuvant chemotherapy for patients with lymph node metastasis from resectable gastric cancer - CDDP+S-1 as neoadjuvant chemotherapy for resecatbele lymph node metastatic gastric cancer

ihon University School of Medicine0 个研究点目标入组 50 人开始时间: 2012年10月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • A history of other malignancies within the last 5 years except for adequately treated non-melanoma skin cancer or carcinoma in situ of the cervix, patients contraindicated to S-1, A history of severe drug hypersensitivity, Uncontrolled medical conditions , Documented or suspected infection, Patients requiring treatment with corticosteroids except for pre-medication, Hepatitis B or C, patients with diarrhea, Pregnant or lactating women and women of child bearing potential not using contraception, Severe psychiatric disorders, Severe edema, Grade 2 or grater peripheral neuropathy, HIV positive, patients judged by the investigator as unfit to be enrolled in the study.

研究者

发起方
ihon University School of Medicine

相似试验